Acquisition history
- Pharmacia (Merged 1995) Farmitalia Carlo Erba. Kabi Pharmacia. Pharmacia Aktiebolaget.
- The Upjohn Company (Merged 1995)
- Monsanto (Merged 2000, divested 2002)
- Searle (Merged 2000)
Pfizer Inc. is a pharmaceutical company that created many well-known drugs. Pfizer brands include Advil, Bextra, Celebrex, Diflucan, Lyrica, Robitussin and Viagra. The Big Pharma company is also the mastermind behind many popular consumer products.The biggest: Humira and Lipitor
In the time of patent loss, between 2011 and 2012, Pfizer's revenue through Lipitor dropped by some 60 percent. Both, Humira and Lipitor, are currently the leading drugs by lifetime sales.
Who owns Pfizer today : The three top individual/insider shareholders in Pfizer are Frank A. D'Amelio, Mikael Dolsten, and Albert Bourla. The three top institutional shareholders are Vanguard Group, BlackRock, and State Street.
Is Johnson and Johnson buying Pfizer
Health care products maker Johnson & Johnson said Monday it is buying the consumer health care unit of drug maker Pfizer for $16.6 billion in cash.
Does Pfizer own Viatris : As of the closing of the combination, Pfizer stockholders owned approximately 57% of the outstanding shares of Viatris common stock, and Mylan shareholders owned approximately 43% of the outstanding shares of Viatris common stock, in each case on a fully diluted, as-converted and as-exercised basis.
Key Takeaways
- Pfizer is one of the leading companies in the biotechnology and pharmaceutical industry.
- Pfizer's top-selling drugs in FY 2022 were Paxlovid and Eliquis.
- Pfizer's main competitors are Johnson & Johnson, Novo Nordisk A/S, Roche Holding AG, Eli Lilly and Co., AbbVie Inc., and Merck & Co.
Pfizer Inc. manufactures, markets and/or distributes more than 315 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Why is Pfizer trading so low
Pfizer is a cheap stock trading at a valuation well below the broader market. The company has experienced declining revenue and earnings over the past year as Covid-19 product sales have dropped.The Consumer Healthcare business is currently a joint venture between GSK and Pfizer Inc (“Pfizer”), with GSK holding a majority controlling interest of 68 per cent. and Pfizer holding 32 per cent.In 2006, Johnson & Johnson acquired Pfizer's consumer healthcare business and merged it with its consumer healthcare business group.
Originally marketed by the Lambert Pharmacal Company (which later became Warner–Lambert), Listerine has been manufactured and distributed by Johnson & Johnson since that company's acquisition of Pfizer's consumer healthcare division on December 20, 2006.
Is Janssen owned by Pfizer : Janssen is a worldwide group of pharmaceutical companies: Part of Johnson & Johnson, the USA based Healthcare Corporation.
Did Pfizer merge with Mylan : Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan. NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc.
When did Viatris split from Pfizer
November 16, 2020
Pfizer spun off its Upjohn unit which immediately merged with Mylan to form Viatris, effective November 16, 2020 in a transaction meant to be tax-free to Pfizer shareholders.
The five biggest pharmaceutical companies by market cap are Eli Lilly, Novo Nordisk, Johnson & Johnson, Merck & Company and AbbVie. The pharmaceutical industry is a major player in the overall life science sector, responsible for developing and manufacturing the majority of prescription drugs.Ranked: The Top 50 Pharmaceutical Giants
| Ranking | Name | Market Cap Oct 16 2023 |
|---|---|---|
| 1 | Eli Lilly | $578.3B |
| 2 | Novo Nordisk | $452.8B |
| 3 | Johnson & Johnson | $377.7B |
| 4 | Merck | $263.9B |
Who is Pfizer biggest rival : They include Johnson & Johnson (JNJ), Roche Holding AG (RHHBY), Eli Lilly and Co. (LLY), AbbVie Inc. (ABBV), Novo Nordisk (NVO), and Merck & Co.